HomeFBRX • NASDAQ
add
Forte Biosciences Inc
Previous close
$5.25
Day range
$5.57 - $5.97
Year range
$4.11 - $28.68
Market cap
36.79M USD
Avg Volume
42.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.35M | 15.20% |
Net income | -7.16M | -21.85% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.34M | -15.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.36M | 57.21% |
Total assets | 61.56M | 57.93% |
Total liabilities | 9.08M | 147.71% |
Total equity | 52.48M | — |
Shares outstanding | 6.58M | — |
Price to book | 0.64 | — |
Return on assets | -46.23% | — |
Return on capital | -59.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.16M | -21.85% |
Cash from operations | -10.01M | -11.60% |
Cash from investing | -35.99M | -224,818.75% |
Cash from financing | 51.88M | 69,269.33% |
Net change in cash | 5.88M | 164.91% |
Free cash flow | -5.09M | 30.31% |
About
Founded
2007
Headquarters
Website
Employees
14
